Close

Truist Securities on Roivant Sciences (ROIV): 'RVT-3101 looks competitive in UC with differentiated safety/efficacy profile'

January 4, 2023 9:35 AM EST Send to a Friend
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $19.00 price target on Roivant Sciences (NASDAQ: ROIV)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login